Cardiac diagnostics and monitoring
Atrial fibrillation
Discover the benefits of continuous cardiac monitoring for atrial fibrillation (AF) diagnosis and management.
5x
Patients with AF are five times more likely to have a stroke.1
40%
AF-related stroke carries a 40% higher risk of severe stroke and mortality than non-AF related stroke.2
10%–40%
Asymptomatic AF varies from 10% to 40% depending on the patient population.3
30%
Approximately 30% of AF is paroxysmal in patients with known AF.4
Symptoms are not a reliable indicator of AF,3 and short-term and intermittent cardiac monitoring may miss many patients with paroxysmal AF.5,6
Watch clinicians discuss the importance of long-term cardiac monitoring to detect AF and prevent secondary stroke.
When patients have unexplained or intermittent symptoms, 30 days of monitoring may not be sufficient. The LINQ™ family of ICMs (Reveal LINQ™ ICM and LINQ II™ ICM) work continuously to capture comprehensive and actionable data over a longer period of time than short-term monitors to deliver superior yield that can increase the rate of diagnosis of unknown AF.
Discover how Reveal LINQ™ ICM compared to standard monitoring for atrial fibrillation detection in cryptogenic stroke patients.
Explore the results of this study, which evaluated continuous, long-term monitoring with Reveal LINQ™ ICM for patients at high risk for atrial fibrillation and stroke.
Review the results of this study, which evaluated the use of ICMs for AF detection in large- and small-vessel stroke patients.
The LINQ™ family of ICMs provides physicians with longitudinal data to objectively determine both asymptomatic and symptomatic AF. This data results in the measure of true AF burden and accurate characterization of the AF type to effectively guide therapy decisions.12,13
Watch clinicians explain AF burden and why it’s important when managing AF patients.
Watch clinician experts share best practices based on their experience managing AF patients and explain why long-term monitoring is beneficial for AF.
69%
of patients had at least one AF recurrence.15
46%
of the recurrent AF being asymptomatic15
Allow for customization by clinic and/or individual patient.
When you need answers, trust the most accurate ICM on the market.19–31 Our proven ICMs deliver the data you need to make the right diagnosis for your patients.32
The LINQ™ family of ICMs provides data that physicians may use to guide medical management decisions, including the titration of anticoagulation.18, 33–35
Maintain high detection sensitivity while reducing false episode review burden.36
1,000+ published clinical articles and abstracts32
One-third the size of a AAA battery (1.2 cc)
< 5 minutes insertion time38,39
™*Third-party brands are trademarks of their respective owners.
† Compared to standard of care.
‡ Based on Kaplan-Meier estimates.
§ Medtronic CareAlert™ notifications are not intended to be used as the sole basis for making decisions about patient medical care.
You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.